Status:

WITHDRAWN

Does rTMS Induce Synaptic Plasticity?

Lead Sponsor:

Davidzon, Guido, M.D.

Collaborating Sponsors:

Stanford University

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

18-70 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to utilize the radioactive positron emission tomography (PET) tracer \[11C\]UCB-J to investigate the effect of repetitive transcranial magnetic stimulation (rTMS) on synap...

Detailed Description

The objective of this project is to discover the neural mechanisms by which Major Depressive Disorder (MDD) is treated, so that we may gain insights into its pathophysiology, as well as to develop new...

Eligibility Criteria

Inclusion

  • 18-70 years in age
  • U.S. Veteran
  • Diagnosis of MDD
  • On a stable medication regimen for at least two weeks prior to testing
  • Stable social environment and housing to enable regular attendance at clinic visits
  • Ability to undergo cognitive testing, clinical assessments, and PET/MR scans
  • Stable medical health
  • Will undergo rTMS treatment for MDD at the VA Palo Alto
  • Able to complete a PET-MR scan without the use of sedation

Exclusion

  • Active substance use within three months of testing
  • IQ \< 70
  • Major medical neurological illness or significant head trauma
  • Pregnancy or breastfeeding
  • Contraindication to MR scanning, including magnetic-resonance incompatible metal or hardware including pacemakers, cochlear implants, and bullets near a critical organ
  • Weight \> 350 lbs or a large body habitus that MR scanner cannot accommodate
  • History of or current claustrophobia
  • Inability to comply with basic study requirements such as following directions and punctuality
  • Acute or unstable chronic medical illness that would affect participation or compliance with study procedures, e.g. unstable angina
  • Unstable psychiatric symptoms that precludes consistent participation in the study, e.g. active current suicidal intent or plan, severe psychosis
  • Inability to undergo PET/MR scan, e.g. claustrophobia, presence of ferromagnetic objects in subject's body

Key Trial Info

Start Date :

December 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04311619

Start Date

December 1 2019

End Date

February 1 2025

Last Update

December 2 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

VA Palo Alto Health Care System

Palo Alto, California, United States, 94304

2

Stanford University

Stanford, California, United States, 94305

Does rTMS Induce Synaptic Plasticity? | DecenTrialz